MRK vs CI
By Alex · Tickerpine
Merck & Co., Inc. vs The Cigna Group, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | MRK | CI |
|---|---|---|
| Price | $148.78 | $272.01 |
| Market cap | $367.07B | $71.88B |
| P/E ratio | 119.0 | 11.2 |
| ROE | 6.96% | 16.76% |
| Profit margin | 4.77% | 2.27% |
| Revenue growth | 5.10% | 6.70% |
| Dividend yield | 2.29% | 2.29% |
| Beta | 0.23 | 0.32 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
MRK vs CI in plain English
- MRK is the bigger company — about 5.1× the market cap of CI.
- CI is cheaper on earnings (P/E 11.2 vs 119.0).
- CI earns a higher return on equity (17% vs 7%).
- CI is growing revenue faster (7% vs 5%).
- CI has the higher dividend yield (2.29% vs 2.29%).
How would $1,000 have done in each?
MRK return calculator
See what $1,000 in Merck & Co., Inc. would be worth today.
CI return calculator
See what $1,000 in The Cigna Group would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.